Back to search

Article

HIV-1 Pretreatment and Acquired Antiretroviral Drug Resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique Running title: Pretreatment and Acquired HIV Drug Resistance in Mozambique

2024-04-08

Abstract excerpt

<title>Abstract</title> <p>Introduction The World Health Organization (WHO) recommends that HIV treatment scale-up is accompanied by a robust assessment of drug resistance emergence and transmission. Included in the WHO HIV Drug Resistance (HIVDR) monitoring and surveillance strategy is HIVDR testing in adults both initiating and receiving antiretroviral therapy (ART). Due to limited information about HIVDR in M...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
39dd895b-1e63-50c0-b350-8fc4d9ae48ba
DOI
10.21203/rs.3.rs-4087034/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HIV-1 Pretreatment and Acquired Antiretroviral Drug Resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique Running title: Pretreatment and Acquired HIV Drug Resistance in MozambiqueDOI 10.21203/rs.3.rs-4087034/v1
Select a neighboring publication to make it the new centre.